09.04.2019 • News

Italmatch Buys Norway’s Eco Inhibitors

Italmatch Buys Norway’s Eco Inhibitors
Italmatch Buys Norway’s Eco Inhibitors

In its first deal of the year, Italian specialty chemicals group Italmatch Chemical has acquired Eco Inhibitors, a Norwegian technology start-up that has developed a new generation of eco-friendly hydrate inhibitors for oil & gas applications. Financial terms were not disclosed.

Italmatch said the acquisition allows it to further consolidate its focus on R&D and sustainability, specifically expanding and refining its current product range as well as reaching new high added-value market targets.

“With Eco Inhibitors knowhow, we are proud to present to the market products with high environmental compatibility, in particular a class of inhibitors derived from recovered salmon waste that represents a perfect example of circular economy,” said Italmatch CEO Sergio Iorio, “The first game-changing green anti-agglomerant is the cutting edge technology that we are going to industrialize.”

Through its Advanced Water Solutions business unit, the Genoa-headquartered company will manufacture and commercialize three classes of low-dosage hydrate inhibitors for optimizing flow assurance in oil & gas deepwater production.

In December 2018, Italmatch agreed to buy BWA Water Additives, a UK provider of water management technologies for the oil & gas, industrial water treatment and desalination industries. The transaction was scheduled to complete in the first quarter of 2019.

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read